Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pine

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Biochimica Et Biophysica Acta|October 12, 1994
Cholesterol limits estrogen uptake by liposomes and erythrocyte membranesM K Jacobsohn, S Bauder, S R Pine, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Glucocorticoid receptor cleavage by leupeptin-sensitive enzymes in rat kidney cytosolM R Sherman, D Barzilai, P R Pine, et al.
Genes & Development|September 1, 1989
Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitroD E Levy, D S Kessler, R Pine, et al.
Carcinogenesis|August 20, 2021
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistanceHatem E Sabaawy, Bríd M Ryan, Hossein Khiabanian, et al.
Theranostics|November 23, 2019
Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapyOlga B Garbuzenko, Andriy Kuzmov, Oleh Taratula, et al.
The Journal of Biological Chemistry|July 5, 1996
The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expressionM David, G Zhou, R Pine, et al.
Heliyon|March 5, 2021
Towards improving the biocompatibility of prosthetic eyesKeith R Pine, Karnika De Silva, Fengqian Zhang, et al.
Frontiers in Oncology|February 4, 2017
Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized MedicineKatherine M Morgan, Gregory M Riedlinger, Jeffrey Rosenfeld, et al.
Molecular and Cellular Biology|June 1, 1990
Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of eitherR Pine, T Decker, D S Kessler, et al.
Genes & Development|April 1, 1988
Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional controlD E Levy, D S Kessler, R Pine, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Biochimica Et Biophysica Acta|October 12, 1994
Cholesterol limits estrogen uptake by liposomes and erythrocyte membranesM K Jacobsohn, S Bauder, S R Pine, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Glucocorticoid receptor cleavage by leupeptin-sensitive enzymes in rat kidney cytosolM R Sherman, D Barzilai, P R Pine, et al.
Genes & Development|September 1, 1989
Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitroD E Levy, D S Kessler, R Pine, et al.
Carcinogenesis|August 20, 2021
JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistanceHatem E Sabaawy, Bríd M Ryan, Hossein Khiabanian, et al.
Theranostics|November 23, 2019
Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapyOlga B Garbuzenko, Andriy Kuzmov, Oleh Taratula, et al.
The Journal of Biological Chemistry|July 5, 1996
The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expressionM David, G Zhou, R Pine, et al.
Heliyon|March 5, 2021
Towards improving the biocompatibility of prosthetic eyesKeith R Pine, Karnika De Silva, Fengqian Zhang, et al.
Frontiers in Oncology|February 4, 2017
Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized MedicineKatherine M Morgan, Gregory M Riedlinger, Jeffrey Rosenfeld, et al.
Molecular and Cellular Biology|June 1, 1990
Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of eitherR Pine, T Decker, D S Kessler, et al.
Genes & Development|April 1, 1988
Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional controlD E Levy, D S Kessler, R Pine, et al.
Pageof 14